Saccade testing in the diagnosis and treatment of type 3 Gaucher disease.
Pensiero
S
S
Department of Ophthalmology, IRCCS Burlo Garofolo, Trieste, Italy.
Accardo
A
A
Pittis
M G
MG
Ciana
G
G
Bembi
B
B
Perissutti
P
P
D001767:Blinking / Q000187:drug effects / Q000502:physiology; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology*; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D005776:Gaucher Disease / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000172:deficiency / Q000235:genetics; D006801:Humans; D008297:Male; D009460:Neurologic Examination; D015835:Ocular Motility Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D012438:Saccades / Q000187:drug effects; D013163:Splenomegaly / Q000209:etiology; D016896:Treatment Outcome
D005962:Glucosylceramidase; C090568:imiglucerase